TECTONIC THERAPEUTIC, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
TECTONIC THERAPEUTIC, INC. (TECX) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $706.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2023-11-09
- 2023-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $706.00K.
- 2023-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.41M.
- 2023-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $2.10M.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2023-09-30 | $706.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.41M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.10M 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |